Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16220288rdf:typepubmed:Citationlld:pubmed
pubmed-article:16220288lifeskim:mentionsumls-concept:C0553662lld:lifeskim
pubmed-article:16220288lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:16220288lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:16220288lifeskim:mentionsumls-concept:C1706513lld:lifeskim
pubmed-article:16220288lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:16220288lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:16220288pubmed:issue8lld:pubmed
pubmed-article:16220288pubmed:dateCreated2006-5-10lld:pubmed
pubmed-article:16220288pubmed:abstractTextThe objectives of this study were to determine genotypic and allelic frequencies of macrophage migration inhibitory factor (MIF) gene -173 G/C polymorphism in patients with juvenile rheumatoid arthritis (JRA) and to evaluate the association of the MIF -173 C allele with the outcome of JRA. Genomic DNA was collected from 67 JRA patients and 153 healthy individuals. To evaluate the association of the MIF -173 polymorphism with the outcome, we analyzed the data concerning the treatment regimen, duration of glucocorticoid treatment, score on the childhood health assessment questionnaire (C-HAQ) and the number of joints with active arthritis. Nonsignificant differences were observed between the study and control groups in the distribution of genotype and allele frequencies of the MIF gene -173 G/C polymorphism. In JRA patients, carrying a MIF -173 C allele, the number of disease modifying antirheumatic drugs required for the treatment was more, the duration of glucocorticoid treatment was significantly longer, and at the last visits the C-HAQ scores and the number of joints with active arthritis were significantly higher. MIF gene -173 C allele frequency did not differ between the controls and JRA patients. MIF -173 C allele did not confer increased susceptibility to JRA in our study group. Carriage of the MIF -173 C allele was found to be a strong predictor of poor outcome in all types of JRA.lld:pubmed
pubmed-article:16220288pubmed:languageenglld:pubmed
pubmed-article:16220288pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16220288pubmed:citationSubsetIMlld:pubmed
pubmed-article:16220288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16220288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16220288pubmed:statusMEDLINElld:pubmed
pubmed-article:16220288pubmed:monthJunlld:pubmed
pubmed-article:16220288pubmed:issn0172-8172lld:pubmed
pubmed-article:16220288pubmed:authorpubmed-author:LeventErtürkElld:pubmed
pubmed-article:16220288pubmed:authorpubmed-author:OzyürekArif...lld:pubmed
pubmed-article:16220288pubmed:authorpubmed-author:GürsesDolunay...lld:pubmed
pubmed-article:16220288pubmed:authorpubmed-author:UlgerZülalZlld:pubmed
pubmed-article:16220288pubmed:authorpubmed-author:BerdeliAfigAlld:pubmed
pubmed-article:16220288pubmed:authorpubmed-author:SalarKorayKlld:pubmed
pubmed-article:16220288pubmed:authorpubmed-author:GürpinarAli...lld:pubmed
pubmed-article:16220288pubmed:issnTypePrintlld:pubmed
pubmed-article:16220288pubmed:volume26lld:pubmed
pubmed-article:16220288pubmed:ownerNLMlld:pubmed
pubmed-article:16220288pubmed:authorsCompleteYlld:pubmed
pubmed-article:16220288pubmed:pagination726-31lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:meshHeadingpubmed-meshheading:16220288...lld:pubmed
pubmed-article:16220288pubmed:year2006lld:pubmed
pubmed-article:16220288pubmed:articleTitleAssociation of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis.lld:pubmed
pubmed-article:16220288pubmed:affiliationDepartment of Pediatrics, Laboratory of Molecular Medicine, Ege University School of Medicine, Bornova, 35100, SSK Tepecik Hospital, Izmir, Turkey. afig@med.ege.edu.trlld:pubmed
pubmed-article:16220288pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16220288pubmed:publicationTypeComparative Studylld:pubmed
entrez-gene:4282entrezgene:pubmedpubmed-article:16220288lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16220288lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16220288lld:entrezgene
lhgdn:association:14238lhgdn:found_inpubmed-article:16220288lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16220288lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16220288lld:pubmed